ensartinib
Showing 1 - 1 of 1
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Beijing, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Peking Uni
Aug 10, 2022